Published in Arch Surg on December 01, 2012
European Association of Endoscopic Surgeons (EAES) consensus statement on the use of robotics in general surgery. Surg Endosc (2014) 0.96
A cost evaluation methodology for surgical technologies. Surg Endosc (2014) 0.88
Transaxillary robotic thyroid surgery: a preliminary European experience. Eur Thyroid J (2013) 0.83
Robotic versus Open Thyroidectomy for Differentiated Thyroid Cancer: An Evidence-Based Review. Int J Endocrinol (2016) 0.81
Cosmetic result and overall satisfaction after minimally invasive video-assisted thyroidectomy (MIVAT) versus robot-assisted transaxillary thyroidectomy (RATT): a prospective randomized study. World J Surg (2014) 0.79
Cost comparison of open approach, transoral laser microsurgery and transoral robotic surgery for partial and total laryngectomies. Eur Arch Otorhinolaryngol (2014) 0.79
Robot-assisted transaxillary thyroid surgery: as safe as conventional-access thyroid surgery? Eur Thyroid J (2013) 0.77
[Alternative approaches in thyroid surgery]. Chirurg (2017) 0.75
Effect of the vascular endothelial growth factor receptor-2 antibody DC101 plus gemcitabine on growth, metastasis and angiogenesis of human pancreatic cancer growing orthotopically in nude mice. Int J Cancer (2002) 2.12
Surgeon-performed ultrasound can predict differentiated thyroid cancer in patients with solitary thyroid nodules. Ann Surg Oncol (2009) 2.09
Comparison of intraoperative iPTH assay (QPTH) criteria in guiding parathyroidectomy: which criterion is the most accurate? Surgery (2003) 2.03
Thyroid cancer: is the incidence still increasing? Ann Surg Oncol (2004) 1.82
Thyroidectomy remains an effective treatment option for Graves' disease. Am J Surg (2006) 1.67
Quick intraoperative parathyroid hormone assay: surgical adjunct to allow limited parathyroidectomy, improve success rate, and predict outcome. World J Surg (2004) 1.32
Blockade of vascular endothelial growth factor receptor and epidermal growth factor receptor signaling for therapy of metastatic human pancreatic cancer. Cancer Res (2002) 1.23
Long-term survival after surgical management of neuroendocrine hepatic metastases. HPB (Oxford) (2010) 1.17
Surgical treatment of non-functioning pancreatic islet cell tumors. J Surg Oncol (2005) 1.16
Fine needle aspiration of the thyroid: correlation with final histopathology in a surgical series of 797 patients. J Am Coll Surg (2011) 1.16
Surgical management of primary hyperparathyroidism: state of the art. Surg Clin North Am (2009) 1.06
A novel optical approach to intraoperative detection of parathyroid glands. Surgery (2013) 1.02
Progress in the operative management of sporadic primary hyperparathyroidism over 34 years. Ann Surg (2004) 1.00
Role of intraoperative parathormone monitoring during parathyroidectomy in patients with discordant localization studies. Surgery (2008) 0.98
Resident education in 2011: three key challenges on the road ahead. Surgery (2011) 0.98
Surgeon-performed ultrasound: a single institution experience in parathyroid localization. Surgery (2009) 0.95
Label-free intraoperative parathyroid localization with near-infrared autofluorescence imaging. J Clin Endocrinol Metab (2014) 0.94
Operative failure in the era of focused parathyroidectomy: a contemporary series of 845 patients. Arch Surg (2010) 0.93
Parathyroidectomy outcomes according to operative approach. Am J Surg (2007) 0.93
Developments in the use of ultrasound for thyroid cancer. Curr Opin Oncol (2010) 0.93
Sporadic primary hyperparathyroidism in young individuals: different disease and treatment? J Surg Res (2008) 0.91
Adrenocorticotropic hormone-secreting pancreatic islet cell carcinoma. J Am Coll Surg (2004) 0.91
Activation of the Sonic Hedgehog pathway in thyroid neoplasms and its potential role in tumor cell proliferation. Endocr Relat Cancer (2012) 0.90
Long-term results of parathyroidectomy for hypercalcemic crisis. Arch Surg (2006) 0.89
Consequences of targeted parathyroidectomy guided by localization studies without intraoperative parathyroid hormone monitoring. J Am Coll Surg (2006) 0.89
Complete androgen insensitivity syndrome: the role of the endocrine surgeon. Am Surg (2005) 0.89
Toxic nodular goiter and cancer: a compelling case for thyroidectomy. Ann Surg Oncol (2012) 0.88
Is potassium iodide solution necessary before total thyroidectomy for Graves disease? Ann Surg Oncol (2013) 0.88
Cancer after thyroidectomy: a multi-institutional experience with 1,523 patients. J Am Coll Surg (2013) 0.88
Predictors of hemodynamic instability during surgery for pheochromocytoma. Ann Surg Oncol (2014) 0.86
Use of ultrasound in the management of thyroid cancer. Oncologist (2010) 0.86
Impact of surgical mentorship on retroperitoneoscopic adrenalectomy with comparison to transperitoneal laparoscopic adrenalectomy. Am Surg (2013) 0.85
Differentiating familial hypocalciuric hypercalcemia from primary hyperparathyroidism. Endocr Pract (2013) 0.84
Pheochromocytoma presenting with multiple organ failure. Am Surg (2008) 0.84
A prospective evaluation of the effect of sample collection site on intraoperative parathormone monitoring during parathyroidectomy. Surgery (2008) 0.83
Metastatic choriocarcinoma to the pancreas. Am Surg (2005) 0.83
Total thyroidectomy for Graves' disease: compliance with American Thyroid Association guidelines may not always be necessary. Surgery (2013) 0.83
Are patients of low socioeconomic status receiving suboptimal management for pancreatic adenocarcinoma? Cancer (2010) 0.83
Short-term outcomes of parathyroidectomy in patients with or without 25-hydroxy vitamin D insufficiency. J Surg Res (2007) 0.82
Oral vitamin D supplementation reduces the incidence of eucalcemic PTH elevation after surgery for primary hyperparathyroidism. Surgery (2007) 0.82
Recurrent disease after limited parathyroidectomy for sporadic primary hyperparathyroidism. J Am Coll Surg (2004) 0.81
Same-day ultrasound guidance in reoperations for locally recurrent papillary thyroid cancer. Surgery (2007) 0.80
Thyroidectomy as primary treatment optimizes body mass index in patients with hyperthyroidism. Ann Surg Oncol (2014) 0.80
Mediastinal hyperfunctioning parathyroids: incidence, evolving treatment, and outcome. Am J Surg (2007) 0.80
Does histopathology predict parathyroid hypersecretion and influence correctly the extent of parathyroidectomy in patients with sporadic primary hyperparathyroidism? Surgery (2007) 0.79
Neurofibromatosis-associated pheochromocytoma. J Am Coll Surg (2005) 0.78
An international perspective on ultrasound training and use for thyroid and parathyroid disease. World J Surg (2010) 0.78
Lithium use and primary hyperparathyroidism. Endocr Pract (2011) 0.77
Expression of Receptors for Pituitary-Type Growth Hormone-Releasing Hormone (pGHRH-R) in Human Papillary Thyroid Cancer Cells: Effects of GHRH Antagonists on Matrix Metalloproteinase-2. Horm Cancer (2015) 0.77
Long-term outcome of patients with intraoperative parathyroid level remaining above the normal range during parathyroidectomy. Surgery (2008) 0.77
Primary hyperparathyroidism in the underinsured: a study of 493 patients. Surgery (2011) 0.76
Completion pancreatectomy and duodenectomy for recurrent MEN-1 pancreaticoduodenal endocrine neoplasms. Surgery (2009) 0.76
Surgical management of primary hyperparathyroidism: the case for giving up quick intraoperative PTH assay in favor of routine measurement the morning after. Ann Surg (2005) 0.75
Parathyroid carcinoma arising from four-gland hyperplasia. Endocr Pract (2011) 0.75
The NIH criteria for parathyroidectomy in asymptomatic primary hyperparathyroidism: are they too limited? Ann Surg (2005) 0.75
Curative Surgical Resection of Adrenocortical Carcinoma: Determining Long-term Outcome Based on Conditional Disease-free Probability. Ann Surg (2015) 0.75
Risk of thyroid cancer in Hispanics: a cohort study. Am Surg (2013) 0.75
Superior mesenteric artery syndrome presenting with pneumoperitoneum and pneumomediastinum. Am Surg (2013) 0.75
Changing intraoperative parathyroid hormone collection sites from peripheral to central does not affect predictive accuracy during minimally invasive parathyroidectomy. Ann Surg Oncol (2010) 0.75
Blood Transfusion and Survival for Resected Adrenocortical Carcinoma: A Study from the United States Adrenocortical Carcinoma Group. Am Surg (2017) 0.75